Sude Yarar

Precision oncology in the treatment of patients with bone sarcomas: an up-to-date narrative review

Primary bone sarcomas are rare and biologically heterogeneous malignancies for which therapeutic progress remains limited, particularly in metastatic and recurrent disease. Advances in genomic and molecular profiling have revealed substantial inter- and intratumoral heterogeneity...